News
Novo Nordisk raced to meet demand for its weight-loss drug Wegovy and almost doubled its workforce over five years. Now, the ...
COPENHAGEN (Reuters) -As Novo Nordisk's sales of its blockbuster weight-loss drug Wegovy boomed, the Danish drugmaker raced to expand manufacturing capacity and sales outreach with a hiring spree that ...
Worker-led protests erupted at Microsoft headquarters this week as the tech company promises an “urgent” review of the Israeli military’s use of its technology during the ongoing war in Gaza. A second ...
Its amazing results have been hailed by Jeremy Clarkson, Whoopi Goldberg and The Telegraph’s own Allison Pearson, but from next month, the popular weight-loss drug Mounjaro could become inaccessible ...
Obesity and overweight increase the risk of type 2 diabetes, hypertension, cardiovascular disease and stroke. The quality of ...
After an unusual first quarter in which seven of the biopharma industry’s | Several U.S. pharma companies that had posted ...
2d
InvestorsHub on MSNNovo Nordisk’s Ozempic Secures Canadian Approval for Kidney Disease Use
Novo Nordisk (NYSE:NVO) said Tuesday that Health Canada has expanded the label for its diabetes therapy Ozempic, granting approval for use in patients with chronic kidney disease. The new indication ...
Novo Nordisk announced Monday that U.S. patients can now get a month's supply of Ozempic, the blockbuster diabetes drug, for ...
Japanese company Softbank Group (9984.T) announced on Tuesday that it had signed an agreement with Intel to buy $2bn of its ...
(CNN) - Patients in the United States can now get the popular diabetes and weight loss drug Ozempic for half the price. Novo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results